We are live on ! Find out more
MDSL

M.D. Sass LLC Portfolio holdings

AUM $1.32B
1-Year Est. Return 16.01%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$1.27B
AUM Growth
+$50.2M
Cap. Flow
-$48.7M
Cap. Flow %
-3.84%
Top 10 Hldgs %
40.58%
Holding
55
New
3
Increased
11
Reduced
20
Closed
15

Top Buys

Rank Stock Value
1
SBGI icon
Sinclair Inc
SBGI
+$51.5M
2
JPM icon
JPMorgan Chase
JPM
+$36.9M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$22.3M
4
CVS icon
CVS Health
CVS
+$9.71M
5
HRI icon
Herc Holdings
HRI
+$8.34M

Sector Composition

Rank Sector Weight
1 Healthcare 25.33%
2 Financials 18.71%
3 Industrials 18.6%
4 Consumer Discretionary 12.83%
5 Energy 11.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBGI icon
1
Sinclair Inc
SBGI
$974M
$61.2M 4.83%
+1,825,413
New +$51.5M
AGN
2
DELISTED
Allergan plc
AGN
$60.5M 4.77%
420,090
-5,050
-1% -$673K
VTRS icon
3
Viatris
VTRS
$20.1B
$60.3M 4.75%
1,578,634
-38,350
-2% -$1.35M
EBAY icon
4
eBay
EBAY
$48.6B
$53.1M 4.19%
2,262,795
-25,899
-1% -$581K
SLB icon
5
SLB Ltd
SLB
$77.8B
$48M 3.79%
543,715
+92,250
+20% +$7.58M
LCC
6
DELISTED
US AIRWAYS GROUP INC.
LCC
$47.9M 3.78%
2,527,865
+310,900
+14% +$5.5M
FMC icon
7
FMC
FMC
$1.42B
$47.2M 3.72%
758,980
-576
-0.1% -$33.1K
SNY icon
8
Sanofi
SNY
$104B
$46.6M 3.67%
919,995
-24,700
-3% -$1.26M
SHPG
9
DELISTED
Shire pic
SHPG
$45.3M 3.57%
377,685
-110,900
-23% -$12.3M
PRU icon
10
Prudential Financial
PRU
$41.7B
$44.4M 3.5%
569,143
-4,446
-0.8% -$349K
MCK icon
11
McKesson
MCK
$98.5B
$44.2M 3.48%
344,213
+8,350
+2% +$1.03M
ADT
12
DELISTED
ADT Corp
ADT
$42.6M 3.36%
1,048,186
+166,850
+19% +$6.86M
HRI icon
13
Herc Holdings
HRI
$5.43B
$42.6M 3.36%
640,538
+108,716
+20% +$8.34M
RGA icon
14
Reinsurance Group of America
RGA
$15.7B
$41.7M 3.29%
622,847
+16,550
+3% +$1.12M
CVS icon
15
CVS Health
CVS
$137B
$41.4M 3.26%
728,636
+162,950
+29% +$9.71M
COF icon
16
Capital One
COF
$124B
$39.5M 3.11%
573,909
-10,696
-2% -$720K
IP icon
17
International Paper
IP
$22.3B
$39.1M 3.09%
935,666
+5,042
+0.5% +$224K
CAM
18
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$38.8M 3.06%
665,551
+15,400
+2% +$918K
MET icon
19
MetLife
MET
$61B
$38.8M 3.06%
927,483
-53,456
-5% -$2.3M
CBI
20
DELISTED
Chicago Bridge & Iron Nv
CBI
$37.9M 2.99%
559,263
-63,050
-10% -$3.89M
SLM icon
21
SLM Corp
SLM
$4.57B
$36.1M 2.85%
4,052,970
-99,290
-2% -$867K
JPM icon
22
JPMorgan Chase
JPM
$939B
$35.6M 2.81%
+688,550
New +$36.9M
TW
23
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$35.5M 2.8%
332,300
-70,300
-17% -$6.18M
FL
24
DELISTED
Foot Locker
FL
$35.2M 2.78%
1,038,419
-9,791
-0.9% -$340K
PENN icon
25
PENN Entertainment
PENN
$2.74B
$35.2M 2.78%
2,811,701
-310,052
-10% -$3.74M

Similar funds

M.D. Sass LLC's Q3 2013 Portfolio in Review

As of Q3 2013, M.D. Sass LLC held 55 positions worth $1.27B, up 4.1% from $1.22B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

M.D. Sass LLC withdrew a net $48.7M in Q3 2013, closing 15 positions and reducing 20 holdings. Its most notable exit was Stanley Black & Decker, an estimated $34.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

Against the trend, M.D. Sass LLC opened a new position in Sinclair Inc worth $61.2M.

  • M.D. Sass LLC's largest Q3 2013 buy was Sinclair Inc: 1,825,413 shares worth $61.2M.
  • M.D. Sass LLC added most to Teva Pharmaceuticals in Q3 2013, an estimated $22.3M increase.
  • M.D. Sass LLC's biggest Q3 2013 reduction was EMC CORPORATION, cutting an estimated $21.3M.
  • M.D. Sass LLC fully exited Stanley Black & Decker in Q3 2013, selling an estimated $34.2M.
  • M.D. Sass LLC's ten largest holdings make up 41% of its $1.27B portfolio in Q3 2013.
  • M.D. Sass LLC opened 3 new positions and closed 15 in Q3 2013.
  • M.D. Sass LLC's portfolio value rose 4.1% quarter-over-quarter to $1.27B.

Based on M.D. Sass LLC's 13F filing for Q3 2013, filed 12 Nov 2013.